Evidence map›Paper›PMID 33300261›Full record

ArticleInternational journal of clinical practice2021

Examination of the effect of COVID-19 on sexual dysfunction in women.

Yeliz Kaya, Coşkun Kaya, Tuğba Tahta, Tuğba Kartal, Vehbi Yavuz Tokgöz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Examination of the effect of COVID-19 on sexual dysfunction in women.International journal of clinical practice · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yeliz KayaDepartment of Nursing, Faculty of Health Sciences, Eskisehir Osmangazi University, Eskisehir, Turkey.ORCID https://orcid.org/0000-0003-4277-3960
Coşkun KayaDepartment of Urology, Eskisehir City Hospital, Eskisehir, Turkey.ORCID https://orcid.org/0000-0002-7445-2304
Tuğba TahtaVocational School of Health Services, Ankara Medipol University, Ankara, Turkey.
Tuğba KartalDepartment of Gynecology and Obstetrics, Eskisehir Osmangazi University Health Practice And Research Hospital, Eskisehir, Turkey.
Vehbi Yavuz TokgözDepartment of Gynecology and Obstetrics, Reproductive Endocrinology and Infertility, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.ORCID https://orcid.org/0000-0002-4113-385X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of COVID-19 on sexual dysfunction in women. MATERIAL AND

methodsThe women diagnosed with COVID-19 and hospitalised at a tertiary hospital were included. They completed the Introductory Data Form, the Female Sexual Function Index-(FSFI) and the Short Form-36 Quality of Life Scale (SF-36).

resultsFifteen women between the ages of 19-49 who completed the treatment protocol, discharged at least 14 days before and who had not been diagnosed as sexual dysfunction; sexually active earlier were included in the study. It was detected that weekly sexual intercourse before and after COVID-19 significantly differed (P = .047). The frequency of relationships decreased statistically after COVID-19. The mean value of the FSFI satisfaction score differs from COVID-19 before and after diagnosis (P = .012). The mean satisfaction score before COVID-19 was 3.47, and after COVID-19 was 2.93. The score of the subgroups of FSFI did not differ from COVID-19 before and after diagnosis (P > .050). The median value of SF-36 pain differs from COVID-19 before and after diagnosis (P = .008).

conclusionIt was concluded that the frequency of sexual intercourse and sexual satisfaction in women decreased after COVID-19 disease, and the quality of life scores did not change in a statistically significant way.

Indexed as

COVID-19AdultFemaleHumansMiddle AgedQuality of LifeSARS-CoV-2Sexual BehaviorSurveys and QuestionnairesYoung Adult

Identifiers

PMID33300261
PMCPMC7883257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.